Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,777,595
+$7,173,341 QoQ
Shares Held
621,143
+39.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#76
of 1,348 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Longaeva Partners L.P. holds $71,618,618 across 3 Drug Manufacturers - General names. NVO ranks #1 (41.6% of the industry book) .
All Filings in NVO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,777,595 | 621,143 | Shares | Other | 2026-08-14 | |
| 2025-12-31 | $22,604,254 | 444,266 | Shares | Other | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||